The short version of IGF-1 fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-02-26 and is reviewed periodically as new material appears.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
| Property | Value | Notes |
|---|---|---|
| Primary research area | Obesity and metabolic regulation | Studied in cell, animal, and human models |
| Highest reported trial phase | Phase II | Public summaries describe mixed results |
| Common route in trials | Subcutaneous injection | Typical for peptide therapeutics |
| Regulatory example | 2013 Australian anti-doping review | Classification was debated at the time |
| Approval status | Not approved as a human medicine | Status can change by jurisdiction |
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene.
Haptophytes are similar and closely related to cryptophytes or heterokontophytes. Their chloroplasts lack a nucleomorph, their thylakoids are in stacks of three, and they synthesize chrysolaminarin sugar, which are stored in granules completely outside of the chloroplast, in the cytoplasm of the haptophyte.
Like the East German state newspaper, official Romanian news organs made no mention of the fall of the Berlin Wall in the first days following 9 November 1989. The most notable news in Romanian newspapers of 11 November 1989, was the "masterly lecture by comrade Nicolae Ceaușescu at the extended plenary session of the Central Committee of the Communist Party of Romania," in which the Romanian head of state and party highly praised the "brilliant programme for the work and revolutionary struggle of all our people," as well as the "exemplary fulfillment of economic tasks." What had happened 1,500 km (930 mi) northwest of Bucharest, in divided Berlin, during those days is not even mentioned. Socialism is praised as the "way of the free, independent development of the peoples." The same day, on Bucharest's Brezoianu Street and Kogălniceanu Boulevard, a group of students from Cluj-Napoca attempted a demonstration but were quickly apprehended. It initially appeared that Ceaușescu would weather the wave of revolution sweeping across Eastern Europe, as he was formally re-elected for another five-year term as General Secretary of the Romanian Communist Party on 24 November at the party's XIV Congress. On that same day, Ceaușescu's counterpart in Czechoslovakia, Miloš Jakeš, resigned along with the entire Communist leadership, effectively ending Communist rule in Czechoslovakia.
== Chemical and physical properties == Glucose forms white or colorless solids that are highly soluble in water and acetic acid but poorly soluble in methanol and ethanol. They melt at 146 °C (295 °F) (α) and 150 °C (302 °F) (beta), decompose starting at 188 °C (370 °F) with release of various volatile products, ultimately leaving a residue of carbon. With six carbon atoms, it is classed as a hexose, a subcategory of the monosaccharides. d-Glucose is one of the sixteen aldohexose stereoisomers. The d-isomer, d-glucose, also known as dextrose, occurs widely in nature, but the l-isomer, l-glucose, does not. Glucose can be obtained by hydrolysis of carbohydrates such as milk sugar (lactose), cane sugar (sucrose), maltose, cellulose, glycogen, etc. Dextrose is commonly commercially manufactured from starches, such as corn starch in the US and Japan, from potato and wheat starch in Europe, and from tapioca starch in tropical areas. The manufacturing process uses hydrolysis via pressurized steaming at controlled pH in a jet followed by further enzymatic depolymerization. Unbonded glucose is one of the main ingredients of honey. The term "dextrose" is often used in a clinical (related to patient's health status) or nutritional context (related to dietary intake, such as food labels or dietary guidelines), while "glucose" is used in a biological or physiological context (chemical processes and molecular interactions), but both terms refer to the same molecule, specifically D-glucose.
Sources: en.wikipedia.org
In January 2025, it was estimated that over 90% of Gaza's population had been displaced. Also the United Nations reported in May 2025 that at least 1.9 million people, roughly 90 percent of Gaza's population, had been displaced by the war. Many families had been uprooted repeatedly, in some cases more than ten times, and new evacuation orders have continued to drive further displacement. Families in Gaza largely have no safe place to go. Displacement sites are packed and conditions are unsafe and undignified. Even where space exists, many lack tents or basic shelter materials, and tented areas themselves continue to come under bombardment.
== History == In 2006, first-generation Greek Americans Ted Xenohristos, Ike Grigoropoulos, and Dimitri Moshovitis launched the full-service Cava Mezze restaurant in Rockville, Maryland, with Moshovitis as executive chef. In 2008, Xenohristos, Grigoropoulos, and Moshovitis partnered with Geoff Maites and Kenny Maites to launch a line of dips and spreads, and grew the product line into over 200 stores, including Whole Foods Market. In 2009, Brett Schulman joined them as CEO and co-founder of the fast-casual chain Cava (originally called Cava Mezze Grill, later rebranded as Cava Grill and then simply as Cava). They opened the first Cava restaurant in Bethesda, Maryland, in January 2011. In August 2018, Zoës was acquired by Cava Group, Inc. for $300 million in total enterprise value. In April 2021, Cava Group completed a $190 million series F funding round led by T. Rowe Price, bringing its value to nearly $1.3 billion. Since 2015, the company has raised more than $640 million. By December 2022, the Cava Group had significantly reduced the number of Zoe's Kitchen locations. As of May 2023, all Zoe's Kitchen restaurants had closed, and many had been replaced by Cava restaurants. On June 15, 2023, Cava made its public debut on the NYSE under the symbol CAVA.
The Kizil Caves (also romanized as Qizil or Qyzyl; Uyghur: قىزىل مىڭ ئۆي, lit. 'The Thousand Red Houses'; Chinese: 克孜尔千佛洞; lit. 'Kizil Caves of the Thousand Buddhas') are a set of Buddhist rock-cut caves located near Kizil Township (克孜尔乡; Kèzī'ěr Xiāng) in Baicheng County, Aksu Prefecture, Xinjiang, China. The site is located on the northern bank of the Muzat River 65 kilometres (40 miles) (75 km; 50 miles by road) west of Kucha. This area was a commercial hub of the Silk Road. The caves have an important role in Central Asian art and in the Silk Road transmission of Buddhism, and are said to be the earliest major Buddhist cave complex in China, with development occurring between the 3rd and 8th centuries CE. The caves of Kizil are the earlier of their type in China, and their model was later adopted in the construction of Buddhist caves further east. Another name for the site has been Ming-oi (明屋), although this term is now mainly used for the site of Shorchuk to the east. The Kizil Caves were inscribed in 2014 on the UNESCO World Heritage List as part of the Silk Roads: the Routes Network of Chang'an-Tianshan Corridor World Heritage Site.
Although higher energies can produce more astatine-211, it will produce unwanted astatine-210 that decays to toxic polonium-210 as well. Instead, the maximum energy of the particle accelerator is set to be below or slightly above the threshold of astatine-210 production, in order to maximize the production of astatine-211 while keeping the amount of astatine-210 at an acceptable level.
Acute lymphoblastic leukemia (ALL) cells are CD10+. Follicular lymphoma (follicle centre cell lymphoma) are CD10+. Burkitt Lymphoma cells are CD10+. CD10+ diffuse large B cell lymphoma (CD10+ DLBCL) Marker for germinal center phenotype (CD10, HGAL, BCL6, CD38) are considered a favorable prognostic factor, but CD10+, BCL2+ tumors could have poorer survival. For some authors, CD10 expression in DLBCL does not influence survival. Angioimmunoblastic T cell lymphoma (AITL) are CD10+ and distinguishes AITL from other T cell lymphomas (CD10−) Some benign T cells can be CD10+
Sources: en.wikipedia.org
The Media Act of 1988 facilitated several changes to NOS and the broadcasting system. The Services Department, which was made up of the technical, broadcast, and transmission facilities of the NOS, was privatised, which meant the broadcasting associations were required to pay to use the facilities. The Nederlands Omroepproduktie Bedrijf (Netherlands Broadcast Production Company; NOB) consisted of those facilities, mainly based in Media Park in Hilversum. The Media Act also required broadcasting association members to take up positions on the NOS Board of Directors. A new government commission oversaw content and financial matters, as well as admitting potential new broadcasting associations.
== Morphology == Brucella canis are non-motile organisms and cannot move independently due to the absence of flagella. Brucella are also non-encapsulated, non-spore forming bacteria that replicate in the ER of their host cells. The bacteria are Gram-negative coccobacilli or short rods measuring 0.6 to 1.5 μm long, and 0.5 to 0.7 μm wide, do not have a capsule, do not form spores, and are aerobic. On blood or chocolate agar, colonies are small (~0.5-2 mm after 48-72 hours), convex, non-hemolytic and non-pigmented. Often B. canis colonies can present themselves as rough variants, a reflection of their naturally rough lipopolysaccharide (LPS) phenotype. The optimal growth temperature for B. canis is 37°C, but growth is still possible within the range from 20°C to 40°C. Additionally, the pH range in which B. canis grows most effectively is from pH 6.6-7.4, making this organism neutrophilic in nature. Brucella species, specifically B. canis, possess a highly specialized outer cell envelope characterized by an atypical profile of membrane lipids. Their outer membrane contains very-long-chain fatty acids (VLCFAs) and modified lipid A structures that differ markedly from traditional Gram-negative bacteria. Importantly, B. canis is a "natural rough" Brucella. Its Lipopolysaccharide lacks the O-polysaccharide that is present in smooth strains; an envelope trait that influences colony phenotype and host interaction without implying a-virulence. B.
By contrast, K-selected species display traits associated with living at densities close to carrying capacity, and typically are strong competitors in such crowded niches that invest more heavily in fewer offspring, each of which has a relatively high probability of surviving to adulthood (i.e., low r, high K). Between these two extremes, the American kestrel is one of the few raptor species that lean towards being r-selected. They are able to breed at one year old, have few non-breeding adults in the population, and have larger broods. Their population growth rate is high relative to larger raptors, which typically lean towards being K-selected. This said, older American kestrel pairs generally have larger brood sizes and produce more viable offspring than younger conspecifics.
Because the Apollo 13 Moon landing was aborted, its RTG rests in the South Pacific Ocean, in the vicinity of the Tonga Trench. The Curiosity and Perseverance Mars rover designs selected RTGs to allow greater flexibility in landing sites and longer lifespan than the solar-powered option, as used in prior generations of rovers. RTGs were also used for the Nimbus, Transit and LES satellites. By comparison, only a few space vehicles have been launched using full-fledged nuclear reactors: the Soviet RORSAT series and the American SNAP-10A. In addition to spacecraft, the Soviet Union built 1,007 RTGs to power uncrewed lighthouses and navigation beacons on the Soviet Arctic coast by the late 1980s. Many different types of RTGs (including Beta-M type) were built in the Soviet Union for a wide variety of purposes. The lighthouses were not maintained for many years after the dissolution of the Soviet Union in 1991. Some of the RTG units disappeared during this time—either by looting or by the natural forces of ice/storm/sea. In 1996, a project was begun by Russian and international supporters to decommission the RTGs in the lighthouses, and by 2021, all RTGs had been removed. As of 1992, the United States Air Force also used RTGs to power remotely-located Arctic equipment, and the US government has used hundreds of such units to power remote stations globally. Sensing stations for Top-ROCC and SEEK IGLOO radar systems, predominantly located in Alaska, use RTGs.
Sources: en.wikipedia.org
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.
It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.
Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.
Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.